All posts by imreal

Health

Best Sanitizers, Inc. Celebrates World Food Safety Day on June 7th, 2022, by Offering Complimentary Hand Hygiene Trainings for Food Processors

Leave a comment

[ad_1]

Best Sanitizers, Inc.

Together, we can help keep food safe.


NEVADA CITY, Calif. (PRWEB)

Northern California based Best Sanitizers, Inc. joins the World Health Organization (WHO), US Food & Drug Administration (FDA), and Pan American Health Organization (PAHO) to participate in the annual World Food Safety Day, June 7th, 2022. This year’s campaign is designed to draw global attention and mobilize action to prevent, detect and manage foodborne risks and improve human health. The campaign addresses proper food production and handling practices, contributing to food security, human health, economic prosperity, agriculture, market access, tourism, and sustainable development.

According to WHO, there are 600 million cases of foodborne diseases leading to 420,000 deaths worldwide each year. Foodborne illnesses are preventable, making it crucial for food processors to understand the importance of food safety. Through education and awareness, World Food Safety Day aims to help educate food processors, suppliers, and the public on how to help reduce foodborne diseases.

This year’s theme, “Safer Food, Better Health” emphasizes the role that safe, nutritional food plays in ensuring human health and well-being and calls for a set of specific actions to make food safer. Specifically calling policy makers, food businesses, educational institutions, and consumers to practice and promote safe food handling practices.

This year’s call to action includes:

1.    Policy makers: design public procurement of food so that consumers can access safe and healthy foods.

2.    Food businesses: develop food safety culture and comply with international food standards.

3.    Educational institutions: support education in food safety; engage with families to promote safe food handling.

4.    Consumers: practice WHO’s Five Keys to Safer Food and promote safe food handling at home.

“Together, we can help keep food safe,” stated April Zeman-Lowe, Best Sanitizers’ Director of Sales – Food and Beverage Division. “We are proud to support World Health Organization, FDA, and Pan American Health Organization in their efforts.”

To help show support for World Food Safety Day, Best Sanitizers, Inc. is offering free hand hygiene trainings to qualifying food processing facilities in the United States. Food plants needing guidance and support can learn more and schedule their training by calling Best Sanitizers at 888.225.3267 or emailing sales@bestsanitizers.com.

Best Sanitizers products are used in over 10,000 food processing facilities in the U.S and Canada. Its Alpet® D2 Surface Sanitizer, Alpet® D2 Quat-Free Surface Sanitizer, Alpet® D2 Surface Sanitizing Wipes, Alpet® Sanitizing Soaps and Alpet® Hand Sanitizer Sprays are staples throughout the industry.

For more information on Best Sanitizers, Inc., visit: http://www.bestsanitizers.com.

About Best Sanitizers, Inc.:

Since 1995, Best Sanitizers, Inc. has been providing the Food Processing, Janitorial Sanitation and Healthcare industries with the highest quality hand soaps, hand sanitizers, surface sanitizers and dispensing options available. In addition, Best Sanitizers offers cleaning and sanitizing equipment including footwear sanitizing units, boot scrubbers, doorway foamers, drain foaming accessories, and proportioning and dispensing equipment. You will find our products helping processors large and small reduce the risk of pathogens throughout the U.S.

Best Sanitizers was the first company to achieve an E3 rating for an alcohol-based hand sanitizer, and the first to achieve a D2 rating for an alcohol/quat-based surface sanitizer for food contact surfaces. Best Sanitizers continues to explore new and innovative ways to deliver hand hygiene and surface sanitation solutions to the United States and Canada.

Share article on social media or email:

[ad_2]

Health

From BIG SKY COUNTRY, NANO SHOT Launches a Collection of Natural, Great Tasting Nano-Emulsified CBD/HEMP Beverages

Leave a comment

[ad_1]

News Image

CBD Nano-Emulsified Formulation, 100% Natural, Plant Based, Available in 4 Flavors

When asked about the competitive landscape, Larry replied, “The real competition in the category is with all of the ‘bad actors.’ Products that came before us were often made with cheap isolate or synthetically derived CBD, sometimes even with no CBD at all, and didn’t deliver on their efficacy.



BELGRADE, Mont. (PRWEB)

With stress, anxiety, and mental health issues on the rise in the post pandemic era, Nano Shot is launching their collection of CBD-infused beverages made with real fruit juice, no artificial flavors, zero calories/sugars and NO THC. The product line, with its proprietary NANO emulsification technology, allows adult consumers to experience a near instant calm and relaxing sensation unlike most of the other options in the marketplace. NANO SHOT is the contemporary solution for today’s health and wellness conscious consumer seeking real functionality and is currently available on-line (https://nano-shot.com) and in select markets throughout the US.

The collection is available in ready-to-drink 2oz. bottles and includes four flavors: Blueberry-Pomegranate, Pineapple-Coconut, Mango-Hot Chili (Available 6/22), and Citrus (Available 6/22). Larry Harmon, Creator and Founder of NANO SHOT developed the brand from a very personal space: “My mother was suffering from Parkinson’s disease and I knew that a 100% natural CBD formulation, if created with a strict focus on the most scientifically advanced nano-emulsification process, could provide a product that assists with enhancing the quality of her daily life. I am very proud of our science and our team and can’t wait to spread the NANO SHOT benefit to consumers across the country and the world.”

Harmon Brands, the parent company that created NANO SHOT, was founded in 2020 with the goal of developing and manufacturing natural/plant-based products for the health & wellness marketplace. Seeing so many other CBD products in the market that either contained heavy amounts of sugar, artificial ingredients, and a taste profile that would choke a horse, the Harmon Brands team was determined to deliver a better solution coupled with a natural CBD experience. Said Mike Hope, owner of the popular Rocking R Bar/Ponderosa Social Club located in Bozeman, MT, “Seeing Larry and his team build a business that supports Health and Wellness, gives the community a sense of pride and is a testament to the entrepreneurial and creative spirit that exists in Montana.”

When asked about the competitive landscape, Larry replied, “The real competition in the category is with all of the ‘bad actors.’ Products that came before us were often made with cheap isolate or synthetically derived CBD, sometimes even with no CBD at all, and didn’t deliver on their efficacy. Nano Shot is a CBD ‘shot’ that is 100% natural, plant based and produced with a high-quality nano-emulsion process that boosts absorption and creates more bioavailability in the body. Part of our mission is to help consumers and our customers learn about CBD, Hemp and the different technologies and processes that are used to make high quality solutions that reap the most benefit from products like Nano Shot. This is why we founded CBD University (CBDU) to help dispel myths and share our knowledge.”

The beverage advisory group InterContinental Beverage Capital (IBC), based in New York City, is providing Harmon Brands with brand development and sales and marketing guidance to assist in their company’s evolution and scalability. IBC Partner, Scott Weiermiller who is responsible for the brand’s commercialization believes that “NANO SHOT is the ideal health and wellness beverage addition to our expanding portfolio. We are always seeking unique and proprietary beverage solutions… NANO SHOT is the right solution at the right time.” For more information visit: inbevcapital.com.

Harmon Brands, LLC is headquartered in Belgrade, Montana. For more information visit: http://www.harmonbrands.com

Media contacts:

Larry Harmon

Harmon Brands, LLC IBC

Belgrade, MT

Info@harmonbrands.com

Scott Weiermiller

InterContinental Beverage Capital

New York, NY

Info@inbevcapital.com

https://vimeo.com/710443472/7cf6b59d1f

https://vimeo.com/710444355/55743cd094

Share article on social media or email:

[ad_2]

Health

Food allergy linked to lower risk of SARS-CoV-2 infection

Leave a comment

[ad_1]

News Image

“Identifying the mechanisms for the decreased risk of infection among those with food allergy could be very interesting in considering strategies to prevent the establishment of infection.” Tina V. Hartert, MD, MPH


MILWAUKEE (PRWEB)

Individuals with food allergies are at a lower risk for both infection and household transmission of SARS-CoV-2, the virus that causes COVID-19, according to a new study published in The Journal of Allergy and Clinical Immunology.

The finding was an unexpected outcome of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) study, which was conducted during the early period of the pandemic when there were many questions about the role of asthma and allergic diseases and whether children were infected or played a major role in community transmission, said Tina V. Hartert, MD, MPH, director of the Center for Asthma Research and a professor of medicine and pediatrics at the Vanderbilt University School of Medicine in Nashville.

“The finding of food allergy as a protective factor for infection risk was most surprising,” Dr. Hartert said. “The study objectives were to determine the role of asthma and allergic diseases in infection risk. We suspected, based upon a small amount of data available in March 2020, when this study was conceived, that those with allergic asthma or allergic rhinitis might be protected, but not food allergy. I say it is surprising because there is nothing about food allergy that made us a priori hypothesize that it would be associated with a decreased infection risk.”

By contrast, researchers were “not surprised by the finding that children play a critical role as a reservoir of asymptomatic infection and household transmission, as it is not dissimilar to their role in transmission of many respiratory viral pathogens,” Dr. Hartert said.

Researchers can only speculate on a reason for the food allergy finding until more study is completed. “We surmised that there could be a number of reasons, including behavioral factors that influence exposure, such as those who are food allergic being less likely to eat at restaurants, or less likely to eat at gatherings which requires removal of their mask. However, we assessed these infection risk behaviors biweekly, and adjusting for them did not explain the findings,” Dr. Hartert said.

Researchers hope conducting transcriptomic profiling on the serial nasal samples collected during the study will shed light on the findings. “It is possible that those with food allergy have a mucosal microbiome or mucosal immunity that protects from infection, or it could be that there are other unmeasured behavioral or risk factors that we didn’t measure that account for the finding.” The finding requires replication, and if true, researchers need to understand why it is protective, she said. “Replicating the finding and identifying the mechanisms for the decreased risk of infection among those with food allergy could be very interesting in considering strategies to prevent the establishment of infection.”

The HEROS study monitored more than 4,000 people in nearly 1,400 households including at least one person 21 years-old or younger between May 2020 and February 2021. Dr. Hartert co-led the research with Max A. Seibold, PhD, director of computational biology, and a professor of pediatrics in the Center for Genes, Environment, and Health at National Jewish Health in Denver.

The wide age range of participants in the HEROS study allowed researchers to assess whether infection risk was age dependent. They found children, teenagers, and adults all exhibited equivalent infection risk. However, they found 75% of infected children were asymptomatic, whereas only 59% of infected teenagers and 38% of infected adults were asymptomatic. The study also found once one household member was infected with SARS-CoV-2, the virus usually was transmitted to another family member, known as the secondary attack rate.

Additionally, the HEROS study determined that asthma and allergic rhinitis are not risk factors for SARS-CoV-2 infection. “While we often consider asthma as a risk factor for more severe infection or morbidity from respiratory viral infection, the focus of HEROS was not on SARS-CoV-2 infection severity. The question tested in HEROS was if asthma is a risk factor for infection,” Dr. Hartert said.

While previous studies have found that obesity is a risk factor for severe COVID-19, the HEROS study also found a link between the Body Mass Index (BMI) and the risk of infection. Every 10 point increase in BMI raised the risk of infection by 9%. In this regard, planned analyses of cells collected from nasal swabs of participants before and after SARS-CoV-2, infection may provide clues about the inflammatory environment associated with infection, which may change as BMI increases, according to the investigators. “Here again, the study results refer to risk of infection, not risk of severe infection, and the findings of a linear relationship of infection risk with BMI are very interesting” Dr. Hartert said. “We didn’t see other established risk factors for severe infection – high blood pressure, etc. – as risk factors for infection.”

You can learn more about food allergy on the American Academy of Allergy, Asthma & Immunology website, aaaai.org.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. The AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

[ad_2]

Health

Biomarker in Liquid Biopsy for Lung Cancer Appears More Accurate in Predicting Immunotherapy Response Than Tumor Biopsy

Leave a comment

[ad_1]

“These results will have an impact in the search for biomarkers to predict for immunotherapy outcome in patients with lung cancer as no truly reliable biomarkers have been found yet,” said senior author Dr. Christian Rolfo.


NEW YORK (PRWEB)

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure. Their study was published in the Journal of Experimental & Clinical Cancer Research in June.

The liquid biopsy tests for a biomarker of PD-L1, a protein and target for a type of immunotherapy called checkpoint inhibitors, which helps the patient’s immune system attack and kill cancer cells. This study showed that testing the blood of lung cancer patients for the PD-L1 biomarker gave more accurate predictions of the response and survival for patients with lung cancer than testing for PD-L1 in tissue from lung cancer biopsies, the current standard of care.

The biomarker in blood, named EV PD-L1, comes from extracellular vesicles, which are particles shed from tumor cells. A decrease of PD-L1 in extracellular vesicles in blood could therefore become a useful test to predict which patients with non-small-cell lung cancer could benefit from immunotherapy.

“These results will have an impact in the search for biomarkers to predict for immunotherapy outcome in patients with lung cancer as no truly reliable biomarkers have been found yet,” said senior author Christian Rolfo, MD, PhD, MBA, Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai, Associate Director for Clinical Research in the Center for Thoracic Oncology at The Tisch Cancer Institute, and President of the International Society of Liquid Biopsy. “If validated in larger prospective cohorts of patients, as we are working on now, this protein could complement or substitute for the tissue PD-L1 as the standard of care in these and other types of tumor patients receiving immunotherapy, especially because it is minimally invasive and can be repetitive during treatment, being able to detect changes in the tumor during the treatment in real time.”

Researchers collected blood samples from two cohorts of 33 and 24 patients with non-small-cell lung cancer receiving immune-checkpoint inhibitors before and at the ninth week of treatment. They also included a group of 15 patients receiving chemotherapy as controls. Extracellular vesicles were isolated from blood samples and the protein expression of PD-L1 was measured in each group at both time points.

Researchers also measured imaging scans of patients’ tumors before treatment and evaluated them with an innovative imaging technology called radiomics to create a full model for prediction of immunotherapy response.

This study, led by Dr. Rolfo, included collaboration of experts in radiomics and medical oncology from the United States, Mexico, and Italy.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report’s “Honor Roll” of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children’s Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

[ad_2]

Health

Windsor Palms Care Center of Artesia Announces a Two Day In-Person Clinical Hiring Event

Leave a comment

[ad_1]

News Image


ARTESIA, Calif. (PRWEB)

Windsor Palms Care Center of Artesia, a skilled nursing and rehabilitation center located in Artesia, California, announced today an upcoming in-person hiring event for their care center. They will be offering on-the-spot job offers.

Windsor Artesia is currently seeking Registered Nurses (RNs), Licensed Vocational Nurses (LVNs), and Certified Nursing Assistants (CNAs) to join their award-winning team.

The hiring event will take place on Friday and Saturday, June 10 – 11, from 10:00am to 3:00pm at the Windsor Palms Care Center of Artesia, located at 11900 Artesia Blvd, Artesia, CA 90701. The first 10 applicants will receive a $25 gift card, and welcome bonuses up to $6000 are available. All attendees are recommended to RSVP and bring an updated copy of their resume.

For more information or to RSVP, interested applicants should click the appropriate link:

LVN/RN: https://intsignup.indeed.com/interview/6cc9e731-17dd-4302-aef9-45b7732b62d4

CNA: https://intsignup.indeed.com/interview/5b42eda6-9381-4496-9a5f-8e69e538839a

“We are excited to invite new people to join our award-winning team of care professionals,” stated Roy Bailey, Director of HR Operations. “We hope to give new employees a chance to work in our outstanding facilities that create a culture of healing that is life-affirming, satisfying, humane, and meaningful.”

About Windsor:

Windsor operates 30 care centers and currently employs over 3,500 individuals who come together to offer nursing, therapeutic, sub-acute, and rehabilitation care to their patients. The company is always striving to promote healing and provide hope to their patients. Between all of the Windsor facilities, the collective staff cares for and attends to over 3,400 patients each day. Windsor care centers strive to create an environment that is supportive to both staff members and patients.

People employed by Windsor can look forward to competitive wages, impressive benefits packages and a community-based work environment. Full-time employees receive medical, dental and vision benefits, Flexible Spending accounts, paid vacation, a 401(k)-retirement plan, and numerous voluntary supplemental programs. Each facility also offers in-depth training to employees wanting to enhance their skills and offers various scholarship programs to support their employees’ educational goals. Early this month, Windsor began partnering with the University of Arizona – Global Campus to offer full tuition grants and discounted tuition to its employees and their immediate family members.

To learn more about Windsor, visit their website at http://www.windsorcares.com or call 310-713-4130.

Share article on social media or email:

[ad_2]

Health

Ignite Teen Treatment and Eden Center for Eating Disorders become part of Moriah Behavioral Health

Leave a comment

[ad_1]

Moriah Behaivoral Health Co.

“Uniting as ‘One Moriah’ allows us to bring together our vast clinical talent and management resources to continuously enhance our quality services for clients and families” said Mark Hobbins, President and COO


LAS VEGAS (PRWEB)

Moriah Behavioral Health Co. (“Moriah”), a company focused on developing and acquiring behavioral healthcare facilities and technology to treat high demand therapeutic verticals, today announced that Ignite Teen Treatment and Eden Center for Eating Disorders are now part of Moriah. The programs will continue to treat the same diagnoses and populations now within the mission of Moriah.

The mission at Moriah is contained within the phrase “with you for life”. With you for life at Moriah represents their commitment to engaging clients and their loved ones during treatment and beyond. Client and family alumni support never stops, continuing to provide meetings, activities, and resources.

“I am excited to bring all of the Ignite and Eden programs into Moriah. The Moriah brand brings an integrated service for our families, referral sources, and payers to access our world-class, broad therapeutic continuum of care for mental health” stated Mendi Baron, LCSW, CEO and Founder.

“Uniting as ‘One Moriah’ allows us to bring together our vast clinical talent and management resources to continuously enhance our quality services for clients and families” said Mark Hobbins, President and COO.

Moriah operates a full continuum of care for eating disorder treatment for adolescent and adult females and mood & anxiety treatment for teens, in separate locations. Moriah is dedicated to providing the highest quality treatment for every client while fostering healing and self-discovery.

The mood & anxiety programs at Moriah provide treatment for teens and adolescents with anxiety, depression, self-harm and a range of mental health diagnoses. Moriah programs provide treatment while supporting each client as a person.

The eating disorder program at Moriah provides multiple levels of treatment for adolescent and adult females struggling with eating disorders as a primary diagnosis. Moriah’s team understands the complex nature of eating disorders and the need for support during and after treatment.

About Moriah Behavioral Health Co.

Moriah Behavioral Health Co. is a comprehensive healthcare organization dedicated to the treatment of mood and anxiety disorders along with eating disorders, offered in a warm, homelike setting. Moriah provides a full continuum of care for adolescents and teens of all genders struggling with mood and anxiety disorders as well as adult and adolescent females struggling with eating disorders.

Share article on social media or email:

[ad_2]

Health

NASA Successfully Demonstrates rHEALTH’s Powerful Biomedical Analyzer Onboard Space Station in a First for Space Medicine

Leave a comment

[ad_1]

This is a remarkable accomplishment on so many different levels, only possible with close collaboration of so many exceptional teams.


BEDFORD, Mass. (PRWEB)

rHEALTH today announced that, in partnership with NASA, that its rHEALTH ONE universal biomedical analyzer was successfully demonstrated on-orbit at the International Space Station. Samantha Cristoforetti, the ESA astronaut part of the SpaceX Crew-4 astronaut team, demonstrated first in space operation of the sophisticated biomedical analyzer. She performed experiments across two sessions involving microliter drops of NASA-prepared control samples on May 13, 2022 between 09:00 and 17:00 GMT and again on May 16, 2022 between 10:45 and 18:30 GMT.

The rHEALTH ONE is the most powerful biomedical analyzer successfully tested onboard the space station. It made several firsts with the demonstration. It was the first biomedical analyzer to demonstrate in space the principles of solid-state, sheath-flow focused cytometry. With its optical block technology, it was the first to demonstrate two-lasers, five simultaneous data channels, allowing a new type of dense biological data collection in microgravity. Close to 100 million raw data points, sampled in microsecond time intervals, were collected with each run, which lasted a few minutes each. It was the first to demonstrate a patented in-line microvolume sample loading mechanism for small sample drops, each less than 10 microliters. This mechanism allows for repeated sample loading of scant biological samples in microgravity.

The technical achievement provides new potential capabilities for the space community, including diagnosis and monitoring of spaceflight medical conditions, such as radiation exposure, circadian rhythm disorders, bone loss, and kidney stones. Enabling research studies for these conditions can also be performed directly on-orbit without need for sample downmass, which requires samples to be stored in suboptimal conditions for long-periods of time prior to analysis. Future deep-space exploration missions provide further complex challenges, including limitations in mass, volume, and power for devices and inability to return samples back to Earth for analysis. The rHEALTH technology fulfills this critical need by having broad capabilities to measure cells, cell counts, biomarkers, microorganisms, electrolytes, and enzymes for various sample types, include blood and other bodily fluids.

“This is a remarkable accomplishment on so many different levels, only possible with close collaboration of so many exceptional teams. The demonstration solidifies our belief that the spaceship is a microcosm for our households; each is its own self-contained entity in need of direct access to healthcare,” said Eugene Chan MD, Founder and CEO of rHEALTH.

About rHEALTH

rHEALTH is a company focused on the development and commercialization of its Your Health, AnywhereTM technology. The rHEALTH blood sensor is the subject of multiple XPRIZE awards, NASA contracts, and over a dozen issued patents. The payload was developed with various groups at NASA, ZIN Technologies, and rHEALTH. For more information, visit http://www.rhealth.com.

Share article on social media or email:

[ad_2]

Technology: Computer

New Censorship-Free Search Engine SearchRockit.com Expands Information Beyond Big Tech with Enhanced Privacy

Leave a comment

[ad_1]

My Search. My Business.

“I simply tired of seeing only what big tech thought I wanted to see, and it’s getting worse. Now, big tech is capitalizing on its patron’s privacy rights by compiling their search behavior via cookies and selling it to advertisers and government.” – Steve Marshall, Founder of SearchRockit.com


SAN JOSE, Calif. (PRWEB)

SearchRockit™ accesses information beyond big tech by adding over 1.2 Billion Unique URL’s including images and videos. The search engine is powered by Gibiru™ – and uses Wormhole Technology™ a system that modifies big tech’s search algorithm, that not only eliminates cookie trackers they install on its users’ computers, but also allows customers to conduct queries without being subjected to the “personalization” major search engines insist on. The benefits are quieries with 256-bit https encryption, no tracking cookies and no data selling or logs.

With web censorship by big tech creating barriers for free speech, information suppression is becoming more commonplace and SearchRockit™ will soon have the ability to access censored content, images and videos.

SearchRockit™ also has the advantage of search speeds faster than the NSA Search Engines since it does not install all sorts of personalization and tracking cookies on your system.

SearchRockit™ offers a free mobile version from the Apple App Store or Google Play.

SearchRockit™ is a US company privately held and committed to a more robust search experience.

Share article on social media or email:

[ad_2]

Technology: Computer

TimePayment Accelerates Sales Growth Post-COVID with Key Leadership Hires

Leave a comment

[ad_1]

“We provide our vendor partners with sales coverage teams that are focused solely on their industry. Our hiring of 30 new front-end employees reflects the growth we are seeing in application and funding volume across all of our industries.” – President & CEO Jay Haverty


BURLINGTON, Mass. (PRWEB)

TimePayment, an award-winning FinTech company specializing in commercial equipment lease financing, has concluded a wave of expansion to position itself to excel post-pandemic, including making 30 front-end hires. TimePayment also announced the appointment of Michael Adams as Senior Vice President & Chief Commercial Officer, leading all revenue-related activities at the firm, and Mark Sheehan as Vice President & General Manager of Capital Markets & Strategic Partnerships, with a special focus on bolstering TimePayment’s syndication relationships.

President & CEO Jay Haverty says of expansion, “We strive to provide the best sales support for our vendors. As a result, we provide our vendor partners with sales coverage teams that are focused solely on their industry. Our hiring of 30 new front-end employees reflects the growth we are seeing in application and funding volume across all of our industries.”

In the executive suite, Michael Adams brings 30 years of leading sales and revenue functions in banking, payments and FinTech lending to TimePayment. Adams’ legacy includes growing sales revenue at both Snap Advances and CAN Capital, as well as helping take FinTech payment processor Marqeta through its $15Bn IPO, while boosting customer satisfaction and retention across the board.

Haverty says of Adams, “It’s a tall order asking someone to coordinate and centralize business development and marketing sales automation for some 30+ industry verticals. Mike has both the sales and project management experience to help us gain efficiencies of scale as we continue to enter even more vertical markets and grow our industry specialist sales teams.”

Mark Sheehan has more than 40 years’ experience across the leasing and information technology fields, including leadership roles at Lease Corporation of America, Crestmark Bank, Wintrust Capital, EverBank (now TIAA), PNC and Comdisco. Sheehan has been awarded Top Sales Producer 15 times, and at National City Bank (now PNC), he won the Excel Award, the bank’s highest honor, at the national and regional levels. Sheehan will apply his deep knowledge to bolster Time Payment’s syndication capabilities and explore strategic partnerships with institutional partners, banks and other financial institutions. “People think of us as a micro-ticket lender, but we do so much more than that,” affirms Sheehan. “Our capital market relationships allow us to handle deals of nearly any size on behalf of our vendors.”

“We are always interested in helping our vendors serve as many customers as we can,” says Haverty. “Mark is going to be key in establishing stronger, deeper relationships with financial institutions to expand our credit window and enable us to ultimately say ‘Yes’ to more applicants on behalf of each of our vendors.”

Michael Adams and TimePayment’s Sales team, including its Diversified Industries, POS and Terminal Leasing, and Restaurant and Franchise groups, will be exhibiting at multiple trade shows this summer, including the Automate Conference, June 6–9 in Detroit, MI; the Southeast Acquirers Association’s SEAA 2022, June 13–16 in Atlanta, GA; and the International Manufacturing Technology Show (IMTS), Sept. 12–17 in Chicago, IL. To contact Mark Sheehan about capital markets or strategic partnerships, visit the Contact page at TimePayment.com.

Visit TimePayment.com to learn more about TimePayment’s broad array of financing products and services that help vendors sell more and businesses of all sizes grow.

About TimePayment™

TimePayment is a Boston-based FinTech company owned by affiliates of Fortress Investment Group, a leading, highly diversified global investment manager. TimePayment leads the industry with technology tools and capital that enables equipment sellers and financial intermediaries to offer fast, paperless equipment lease financing to their customers. The company’s proprietary credit scoring and risk-based transaction model delivers competitive lease financing solutions across the credit spectrum; from Fortune 500 companies to small business start-ups. TimePayment proudly serves more than 100,000 active accounts with transaction sizes ranging from $500 to over $500,000.

Share article on social media or email:

[ad_2]

Health

Westbury Group Advises Plastic Surgery Leader Body Sculpt Intl on its Acquisition by Body Contour Centers

Leave a comment

[ad_1]


WESTPORT, Conn. (PRWEB)

Westbury Group LLC (“Westbury”) announced today that its client, Body Sculpt Intl, LLC (“Body Sculpt Intl” or “BSI”) has been acquired by Body Contour Centers, LLC (“Body Contour Centers” or “BCC”), doing business as Sono Bello. The transaction closed in March 2022. Jonathan Rubin and Robert Croddy led the investment banking team for Westbury.

The transaction brings the entire Sono Bello enterprise under Body Contour Centers and positions the business for further growth across the country.

“Jon, Rob, and the entire Westbury team worked tirelessly to bring the transaction to a successful conclusion,” said Mike Garrison, BSI’s CEO. “I and the other shareholders are very pleased with the outcome. We’re excited to be part of the Body Contour Center family and look forward to building Sono Bello over the coming years.”

Mr. Rubin said, “Mike and his entire executive team were top-notch and a pleasure to work with. They were diligent and professional throughout the entire process. They contributed significantly to the great result. The BCC leadership also proved to be great partners in getting the deal done.”

Robert Croddy noted, “The acquisition of BSI by BCC brings the Sono Bello brand under a single entity, reinforcing its position as the leading national brand for safe and effective liposuction surgery. It was a pleasure working with both the BSI and BCC teams and witnessing their passion for improving patients’ lives. We look forward to seeing Sono Bello’s continued growth and success during the coming years.”

About the Westbury Group

The Westbury Group LLC (http://www.westburygroup.com) is an investment bank dedicated to providing exceptional financial and strategic advisory services for premier middle-market companies. Headquartered in Westport, Connecticut, Westbury’s bankers serve clients across the country. Westbury’s finance professionals bring transactional and real-world operations experience to engagements ranging from $25 million to $300+ million. assisting clients with mergers, and acquisitions, raising equity capital and supporting management and boards with advisory services. Westbury Group is a FINRA-registered Broker-Dealer and a member of the International Corporate Finance Group (http://www.icfg.net).

About Body Sculpt Intl

Based in Scottsdale, AZ, Body Sculpt Intl, was founded in 2009. Prior to its acquisition by Body Contour Centers, BSI was the third-largest provider of body contouring surgery and had performed more than 75,000 procedures, operating as a licensee of BCC under the Sono Bello brand. BSI has been a leader in minimally invasive, awake liposuction procedures. Its surgical centers are fully accredited by the Accreditation Association for Ambulatory Health Care (AAAHC).

About Body Contour Centers

Founded in 2008, Body Contour Centers, doing business as Sono Bello, is a national leader in private plastic surgery practice in the United States with over 70 locations across the country. With its head office in Kirkland, WA, BCC operates in 30 states and employs over 500 people. BCC combines a consistent patient experience with the art of treating each patient as an individual with unique plastic surgery needs. BCC has a focused service offering that primarily focuses on less invasive procedures such as laser-assisted body contouring (liposuction), mini tummy tucks, and minor face procedures. These procedures are conducted by over 130 board-certified plastic surgeons and every surgical center is certified by AAAHC, the highest-level certification for plastic surgery. BCC has performed over 250,000 procedures for its patients.

Share article on social media or email:

[ad_2]